Similar Papers

Paper Title
Journal
Date
Author
Updated Trends in Incidence and Survival of Mantle Cell Lymphoma from 2000 to 2020
Ruby Arora ... Nakhle S Saba
Blood | VOL. 142
Ruby Arora, et. al.Ruby Arora ... Nakhle S Saba
02 Nov 2023
Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
Evangelia Peponi ... L Jeffrey Medeiros
The American Journal of Pathology | VOL. 169
Evangelia Peponi, et. al.Evangelia Peponi ... L Jeffrey Medeiros
01 Dec 2006
Frontline chemotherapy-free induction for mantle cell lymphoma.
Umberto Vitolo ... Mattia Novo
The Lancet. Oncology | VOL. 23
Umberto Vitolo, et. al.Umberto Vitolo ... Mattia Novo
01 Mar 2022
Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Mariko Yoshimura ... Archana Dilip
Cancer Science | VOL. 105
Mariko Yoshimura, et. al.Mariko Yoshimura ... Archana Dilip
03 Jun 2014
View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title
Journal
Date
Author
Editorial Board
-
Clinical Lymphoma Myeloma and Leukemia | VOL. -
--
01 Feb 2025
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression
Mohammad Ma'Koseh ... Hikmat Abdel-Razeq
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Mohammad Ma'Koseh, et. al.Mohammad Ma'Koseh ... Hikmat Abdel-Razeq
01 Feb 2025
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia with Azacitidine plus Venetoclax
Joseph Brandwein ... Peng Wang
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Joseph Brandwein, et. al.Joseph Brandwein ... Peng Wang
01 Feb 2025
mRNA expression in DLBCL patients who are CD20 dim with an eye towards more thoughtful design of R/R trials, possibly incorporating BCMA Bite therapy
Bruce Hough ... Maher Albitar
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Bruce Hough, et. al.Bruce Hough ... Maher Albitar
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.